And to date, in our preclinical models, has not shown any sign of hyperglycemia or GI tox ... can tackle recurrent C. diff, a highly potent and orally viable C. diff toxin, B selective inhibitor.

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

It may be found in the Books section of the store at peoplespharmacy.com. Advertising Q: My elderly mother had C. diff, as did a dear friend of mine who had been hospitalized. Both were treated ...

Share on Pinterest A new study suggests that consuming excess poultry may be associated with all-cause mortality and gastrointestinal cancers. Davide Illini/Stocksy United Consuming more than 300 ...

and had been designed to treat C. diff by selectively inhibiting the glucosyltransferase activity of toxin B produced by the bacterium in the gastrointestinal tract, offering a different ...

Recursion Pharmaceuticals Inc. (RXRX) reported its Q1 2025 financial results, revealing a slight miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of -$0.5 ...

Recursion Pharmaceuticals Inc. (RXRX) reported its Q1 2025 financial results, revealing a slight miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of -$0.5 against ...

It was an in-silico study that predicted the microbiome restorative potential of ibezapolstat for treating C. diff. Our scientific advisers consider this to be a major finding, which provides a ...

May 29, 2025 — Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence ...